Skip to main navigation Skip to search Skip to main content

Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson's disease

  • Sinyeon Kim
  • , Jin Gyu Choi
  • , Se Woong Kim
  • , Sang Cheol Park
  • , Yu ra Kang
  • , Dong Seok Park
  • , Miwon Son
  • , Choong Hwan Lee
  • Ltd.

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease, after Alzheimer's disease, and becomes increasingly prevalent with age. α-Synuclein (α-syn) forms the major filamentous component of Lewy bodies, which are pathological hallmarks of α-synucleinopathies such as PD. We evaluated the neuroprotective effects of MT101-5, a standardized herbal formula that consists of an ethanolic extract of Genkwae Flos, Clematidis Radix, and Gastrodiae Rhizoma, against α-synuclein-induced cytotoxicity in vivo. MT101-5 protected against behavioral deficits and loss of dopaminergic neurons in human α-syn-overexpressing transgenic mice after treatment with 30 mg/kg/day for 5 months. We investigated transcriptomic changes within MT101-5 mechanisms of action (MOA) suppressing α-syn aggregation in an α-synuclein preformed fibril (α-syn PFF) mouse model of sporadic PD. We found that inhibition of α-syn fibril formation was associated with changes in transcripts in mitochondrial biogenesis, electron transport, chaperones, and proteasomes following treatment with MT101-5. These results suggest that the mixed herbal formula MT101-5 may be used as a pharmaceutical agent for preventing or improving PD.

Original languageEnglish
Article number113637
JournalBiomedicine and Pharmacotherapy
Volume154
DOIs
StatePublished - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Chaperone
  • Mitochondria
  • MT101-5
  • Parkinson's disease
  • Proteasome
  • α-Synuclein aggregation

Fingerprint

Dive into the research topics of 'Inhibition of α-synuclein aggregation by MT101-5 is neuroprotective in mouse models of Parkinson's disease'. Together they form a unique fingerprint.

Cite this